Selective Lysis of Blood Cells for Bacterial DNA Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The detection of bacterial pathogens in blood samples is hindered by the abundance of human DNA and cellular components, which increases background noise and viscosity, making it challenging to detect low levels of bacterial DNA using PCR-based methods.

Innovation Solution

A method involving the selective lysis of white and red blood cells using a non-ionic detergent and alkaline buffer at a pH of 9.0, allowing bacteria and fungi to remain intact, thereby reducing human DNA interference and improving detection sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If large volumes of blood are used to detect minute amounts of bacteria, then detection sensitivity is improved, but the background noise from human DNA increases dramatically

Engineering Contradiction:
Improvedetection sensitivityVSAvoidbackground noise from human DNA
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and removes human DNA from the blood sample using selective lysis conditions (pH 9.0 buffer with non-ionic detergent) that lyse human cells while preserving bacterial cells. This extraction step eliminates the harmful background noise from human DNA before PCR analysis, enabling sensitive detection of minute bacterial amounts without the interference of abundant human genetic material.

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If whole blood is used directly for PCR detection, then no further processing is needed, but the high amount of cellular material complicates pathogen detection

Engineering Contradiction:
Improvesample processing simplicityVSAvoidpathogen detection difficulty
Core Design Contradiction:
Ease of manufactureVSDifficulty of detecting and measuring

Solution Approach 1:

The patent performs preliminary selective lysis of human cells before the PCR detection step. By pre-treating the blood sample with pH 9.0 buffer and non-ionic detergent to lyse human cells and release their DNA, the subsequent PCR reaction is performed on a simplified sample matrix. This preliminary action removes the complicating cellular material while maintaining bacterial integrity for accurate pathogen detection.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If human cells are lysed to remove human DNA, then detection sensitivity is improved, but proteins and membranes from lysed cells increase sample viscosity

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsample viscosity
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent utilizes specific parameter changes - particularly pH adjustment to 9.0 and the use of non-ionic detergents - to achieve selective lysis of human cells. These parameter changes create conditions where human cell membranes become permeable and rupture, releasing DNA while the subsequent neutralization step (returning pH to 7.0) stabilizes the lysate. This controlled parameter manipulation maximizes DNA release while minimizing viscosity-increasing byproducts.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the sensitivity of bacterial DNA detection by minimizing human DNA interference and maintaining the integrity of bacterial DNA, enabling the detection of minute bacterial amounts in blood samples without compromising RNA stability.

Implementation Method 1

A method involving the selective lysis of white and red blood cells using a non-ionic detergent and alkaline buffer at a pH of 9.0, allowing bacteria and fungi to remain intact

Methodology Applied
Scientific EffectSelective lysis:

Data Source

PatentUS20240084404A1Selective lysis of human blood cells
Publication Date: 2024.03.14 ROCHE MOLECULAR SYSTEMS INC

AI summary

The present invention relates to methods for the specific lysis of eukaryotic cells in a sample containing microorganisms such as bacterium and fungus by incubating the sample in a buffer of around pH 9 that contains a non-ionic detergent.